Skip to Main content Skip to Navigation
New interface
Journal articles

Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen.

Abstract : The tumor-associated glycoprotein 72 (TAG-72) is a membrane mucin whose over-expression is correlated with advanced tumor stage and increased invasion and metastasis. In this study, we identified a panel of four nanobodies, single variable domains of dromedary heavy-chain antibodies that specifically recognize the TAG-72 antigen. All selected nanobodies were shown to selectively bind to this cancer-related molecule with low-nanomolar affinities and do not cross-react with other antigens, such as MUC1 or HER2. Furthermore, they can detect TAG-72 in concentrations as low as 5 U/ml which is valuable in sensitive detection of this molecule in cancerous patients. Cell ELISA experiments proved their ability for binding to the native target antigen on TAG-72 expressing cells while not showing any reactivity to HT-29 cells, a TAG-72-negative cell line. Using competition studies, we found that each nanobody recognizes a distinct epitope on the TAG-72 antigen that is different from the one recognized by the mouse anti-TAG-72 antibody, CC49. Considering their high specificity, reduced immunogenicity and multi-targeting behavior, these oligoclonal nanobodies represent a promising tool to target TAG-72 over-expressing tumor cells.
Document type :
Journal articles
Complete list of metadata

Cited literature [43 references]  Display  Hide  Download
Contributor : Fereidoun Mahboudi Connect in order to contact the contributor
Submitted on : Saturday, May 25, 2013 - 9:01:04 AM
Last modification on : Wednesday, September 7, 2022 - 5:42:43 PM
Long-term archiving on: : Tuesday, April 4, 2017 - 11:18:14 AM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document




Zahra Sharifzadeh, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar, Davoud Ahmadvand, Fereidoun Mahboudi, et al.. Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen.. Molecular Biotechnology, 2013, 54 (2), pp.590-601. ⟨10.1007/s12033-012-9601-0⟩. ⟨pasteur-00825965⟩



Record views